SFX by Ex Libris Inc.

Title:	Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
Source:	Nature Medicine [1078-8956] During, Matthew yr:2003

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Sokos, G. "Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure." Journal of Cardiac Failure 12.9 (2006): 694-699.
description	2.	Bertilsson, G. "Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease." Journal of neuroscience research 86.2 (2007): 326-338.
description	3.	Greig, Nigel H H. "A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells." The Journal of pharmacology and experimental therapeutics 300.3: 958-966.
description	4.	Mentlein, R. "Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum." European journal of biochemistry 214.3 (1993): 829-35.
description	5.	Klugmann, M. "A novel role of circadian transcription factor DBP in hippocampal plasticity." Molecular and cellular neurosciences 31.2 (2006): 303-14.
description	6.	Deacon, C F F. "Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo." The Journal of clinical endocrinology & metabolism 80.3: 952-957.
description	7.	Taupin, P. "BrdU immunohistochemistry for studying adult neurogenesis: Paradigms, pitfalls, limitations, and validation." Brain Research Reviews 53.1 (2007): 198-214.
description	8.	Winkler, J. "Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration." Journal of neuropathology and experimental neurology 67.2 (2008): 105-16.
description	9.	Shannon, Richard P P. "Effect of Glucagon-Like Peptide-1 (GLP-1) on Glycemic Control and Left Ventricular Function in Patients Undergoing Coronary Artery Bypass Grafting." The American journal of cardiology 100.5 (2007): 824-9.
description	10.	Nishikawa, Y. "Circadian changes in long-term potentiation of rat suprachiasmatic field potentials elicited by optic nerve stimulation in vitro." Brain Research (1995): 158-62.
description	11.	Abbas, T. "Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease." Behavioural Brain Research 205.1 (2009): 265-271.
description	12.	Miyazaki, Y. "Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone." Diabetes care 24.4 (2001): 710-9.
description	13.	Quinn, James F. "Motor Memory Consolidation, Night and Day." The journal of neuroscience 25.40 (2005): 9067-9068.
description	14.	Wei, Y. "Distribution of GLP-1 and PACAP receptors in human tissues." Acta physiologica Scandinavica 157.3 (1996): 355-7.
description	15.	Boeve, B. "Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy." Movement disorders 16.4 (2001): 622-630.
description	16.	Perry, T. "The glucagon-like peptides: a new genre in therapeutic targets for intervention in Alzheimer's disease." Journal of Alzheimer's disease 4.6 (2003): 487-96.
description	17.	Abraham, Elizabeth J J. "Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells." Endocrinology 143.8 (2002): 3152-61.
description	18.	Stewart, R. "Type 2 diabetes mellitus, cognitive impairment and dementia." Diabetic medicine 16.2 (1999): 93-112.
description	19.	Chaudhury, D. "Circadian regulation of hippocampal long-term potentiation." Journal of biological rhythms 20.3 (2005): 225-36.
description	20.	Hoglinger, Etienne C U. "Dopamine depletion impairs precursor cell proliferation in Parkinson disease." Nature neuroscience 7.7 (2004): 726-735.